WHO unveils first-ever guidelines for treatment and management of Ebola. [AFP]
The World Health Organization (WHO) has unveiled its inaugural clinical guidelines for managing filovirus diseases, including Ebola and Marburg virus diseases.
These guidelines aim to standardize treatment and enhance survival rates during outbreaks, which continue to impact health systems across Africa.
Developed in response to ongoing outbreaks, the guidelines draw on extensive clinical experience, particularly related to the Bundibugyo virus, which has affected numerous communities and transcended borders from the Democratic Republic of the Congo (DRC) to Uganda.
Filoviruses, a family of highly infectious agents, cause severe viral hemorrhagic fever in both humans and non-human primates, with Ebola and Marburg virus diseases characterized by rapid progression, high mortality rates, and limited diagnostic and treatment options.
